Literature DB >> 21572305

Association of recent HIV infection and in-utero HIV-1 transmission.

Taha E Taha1, Maria M James, Donald R Hoover, Jin Sun, Oliver Laeyendecker, Caroline E Mullis, Johnstone J Kumwenda, Jairam R Lingappa, Bertran Auvert, Charles S Morrison, Lynne M Mofensen, Allan Taylor, Mary G Fowler, Newton I Kumenda, Susan H Eshleman.   

Abstract

OBJECTIVE: We previously developed a multiassay algorithm (MAA) to identify recent HIV infection that includes the BED-capture enzyme immunoassay, an avidity assay based on the Genetic Systems HIV-1/HIV-2 + O enzyme immunoassay, CD4 cell count, and HIV viral load. We used this MAA to evaluate the association between recent maternal HIV infection and in-utero transmission of HIV.
METHODS: Plasma samples were collected at delivery from 2561 HIV-infected women in the postexposure prophylaxis of infants-Malawi trial. The MAA described above was used to identify women with recent HIV infection. Logistic regression models assessed association between recent HIV infection and in-utero HIV transmission (defined as a positive infant HIV DNA test at birth).
RESULTS: Seventy-three women were identified as recently infected using the MAA. Those women were younger and had lower parity than women who were identified as not recently infected using the MAA (P < 0.0001 for age and parity). The frequency of in-utero HIV transmission was 17.8% among women identified as recently infected, compared with 6.7% among women identified as not recently infected (13/73 vs. 166/2488, P = 0.001). In a multivariate model, three factors were independently associated with in-utero HIV transmission: recent infection [adjusted odds ratio (AOR): 2.49, 95% confidence interval (CI): 1.30-4.78, P = 0.006], log(10) HIV viral load at delivery (AOR: 2.01, 95% CI: 1.60-2.51, P < 0.0001), and younger age (per 10 year increase, AOR: 0.66, 95% CI: 0.43-0.93, P = 0.02).
CONCLUSION: Results obtained using a MAA suggest that recent maternal HIV acquisition is strongly associated with in-utero HIV transmission, independent of HIV viral load at delivery.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21572305      PMCID: PMC3263827          DOI: 10.1097/QAD.0b013e3283489d45

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  38 in total

1.  Acute maternal HIV infection during pregnancy and breast-feeding: substantial risk to infants.

Authors:  Shahin Lockman; Tracy Creek
Journal:  J Infect Dis       Date:  2009-09-01       Impact factor: 5.226

Review 2.  HIV incidence in sub-Saharan Africa: a review of available data with implications for surveillance and prevention planning.

Authors:  Sarah L Braunstein; Janneke H H M van de Wijgert; Denis Nash
Journal:  AIDS Rev       Date:  2009 Jul-Sep       Impact factor: 2.500

Review 3.  Primary human immunodeficiency virus type 1 infection.

Authors:  Malini Soogoor; Eric S Daar
Journal:  Curr HIV/AIDS Rep       Date:  2005-06       Impact factor: 5.071

4.  Hormonal contraception and the risk of HIV acquisition.

Authors:  Charles S Morrison; Barbra A Richardson; Francis Mmiro; Tsungai Chipato; David D Celentano; Joanne Luoto; Roy Mugerwa; Nancy Padian; Sungwal Rugpao; Joelle M Brown; Peter Cornelisse; Robert A Salata
Journal:  AIDS       Date:  2007-01-02       Impact factor: 4.177

5.  Maternal HIV-1 viral load and vertical transmission of infection: the Ariel Project for the prevention of HIV transmission from mother to infant.

Authors:  Y Cao; P Krogstad; B T Korber; R A Koup; M Muldoon; C Macken; J L Song; Z Jin; J Q Zhao; S Clapp; I S Chen; D D Ho; A J Ammann
Journal:  Nat Med       Date:  1997-05       Impact factor: 53.440

6.  Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda.

Authors:  Maria J Wawer; Ronald H Gray; Nelson K Sewankambo; David Serwadda; Xianbin Li; Oliver Laeyendecker; Noah Kiwanuka; Godfrey Kigozi; Mohammed Kiddugavu; Thomas Lutalo; Fred Nalugoda; Fred Wabwire-Mangen; Mary P Meehan; Thomas C Quinn
Journal:  J Infect Dis       Date:  2005-03-30       Impact factor: 5.226

7.  Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group.

Authors:  P M Garcia; L A Kalish; J Pitt; H Minkoff; T C Quinn; S K Burchett; J Kornegay; B Jackson; J Moye; C Hanson; C Zorrilla; J F Lew
Journal:  N Engl J Med       Date:  1999-08-05       Impact factor: 91.245

8.  Daily acyclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial.

Authors:  Jairam R Lingappa; Jared M Baeten; Anna Wald; James P Hughes; Katherine K Thomas; Andrew Mujugira; Nelly Mugo; Elizabeth A Bukusi; Craig R Cohen; Elly Katabira; Allan Ronald; James Kiarie; Carey Farquhar; Grace John Stewart; Joseph Makhema; Myron Essex; Edwin Were; Kenneth H Fife; Guy de Bruyn; Glenda E Gray; James A McIntyre; Rachel Manongi; Saidi Kapiga; David Coetzee; Susan Allen; Mubiana Inambao; Kayitesi Kayitenkore; Etienne Karita; William Kanweka; Sinead Delany; Helen Rees; Bellington Vwalika; Amalia S Magaret; Richard S Wang; Lara Kidoguchi; Linda Barnes; Renee Ridzon; Lawrence Corey; Connie Celum
Journal:  Lancet       Date:  2010-02-12       Impact factor: 79.321

9.  Viral dynamics in primary HIV-1 infection. Karolinska Institutet Primary HIV Infection Study Group.

Authors:  S Lindbäck; A C Karlsson; J Mittler; A Blaxhult; M Carlsson; G Briheim; A Sönnerborg; H Gaines
Journal:  AIDS       Date:  2000-10-20       Impact factor: 4.177

10.  A case series of 104 women infected with HIV-1 via blood transfusion postnatally: high rate of HIV-1 transmission to infants through breast-feeding.

Authors:  Ke Liang; Xien Gui; Yuan-Zhen Zhang; Ke Zhuang; Kathrine Meyers; David D Ho
Journal:  J Infect Dis       Date:  2009-09-01       Impact factor: 5.226

View more
  14 in total

1.  Performing Drug Safety Research During Pregnancy and Lactation: Biomedical HIV Prevention Research as a Template.

Authors:  Richard H Beigi; Lisa Noguchi; Gina Brown; Jeanna Piper; D Heather Watts
Journal:  J Womens Health (Larchmt)       Date:  2013-06-29       Impact factor: 2.681

2.  Are infants unique in their ability to be "functionally cured" of HIV-1?

Authors:  Nicole H Tobin; Grace M Aldrovandi
Journal:  Curr HIV/AIDS Rep       Date:  2014-03       Impact factor: 5.071

3.  Acceptability of and Adherence to an Antiretroviral-Based Vaginal Microbicide among Pregnant Women in the United States.

Authors:  Elizabeth T Montgomery; Lisa M Noguchi; James Y Dai; Jason Pan; Joseph Biggio; Craig Hendrix; Karen Isaacs; D Heather Watts; Jill L Schwartz; Jeanna Piper; Richard Beigi
Journal:  AIDS Behav       Date:  2018-02

Review 4.  Paediatric HIV infection: the potential for cure.

Authors:  Philip J Goulder; Sharon R Lewin; Ellen M Leitman
Journal:  Nat Rev Immunol       Date:  2016-03-14       Impact factor: 53.106

Review 5.  Immunology of pediatric HIV infection.

Authors:  Nicole H Tobin; Grace M Aldrovandi
Journal:  Immunol Rev       Date:  2013-07       Impact factor: 12.988

6.  Pregnancy and Infant Outcomes Among Women Using the Dapivirine Vaginal Ring in Early Pregnancy.

Authors:  Bonus Makanani; Jennifer E Balkus; Yuqing Jiao; Lisa M Noguchi; Thesla Palanee-Phillips; Yamikani Mbilizi; Jothi Moodley; Kenneth Kintu; Krishnaveni Reddy; Samuel Kabwigu; Nitesha Jeenariain; Ishana Harkoo; Nyaradzo Mgodi; Jeanna Piper; Helen Rees; Rachel Scheckter; Richard Beigi; Jared M Baeten
Journal:  J Acquir Immune Defic Syndr       Date:  2018-12-15       Impact factor: 3.731

7.  Effect of natural and ARV-induced viral suppression and viral breakthrough on anti-HIV antibody proportion and avidity in patients with HIV-1 subtype B infection.

Authors:  Sarah K Wendel; Caroline E Mullis; Susan H Eshleman; Joel N Blankson; Richard D Moore; Jeanne C Keruly; Ron Brookmeyer; Thomas C Quinn; Oliver Laeyendecker
Journal:  PLoS One       Date:  2013-02-20       Impact factor: 3.240

8.  Detection of Acute and Early HIV-1 Infections in an HIV Hyper-Endemic Area with Limited Resources.

Authors:  Simnikiwe H Mayaphi; Desmond J Martin; Thomas C Quinn; Oliver Laeyendecker; Steve A S Olorunju; Gregory R Tintinger; Anton C Stoltz
Journal:  PLoS One       Date:  2016-10-20       Impact factor: 3.240

9.  Antibody maturation and viral diversification in HIV-infected women.

Authors:  Maria M James; Oliver Laeyendecker; Jin Sun; Donald R Hoover; Caroline E Mullis; Matthew M Cousins; Thomas Coates; Richard D Moore; Gabor D Kelen; Mary Glenn Fowler; Johnstone J Kumwenda; Lynne M Mofenson; Newton I Kumwenda; Taha E Taha; Susan H Eshleman
Journal:  PLoS One       Date:  2013-02-27       Impact factor: 3.240

10.  A randomized safety and pharmacokinetic trial of daily tenofovir 1% gel in term and near-term pregnancy.

Authors:  Richard H Beigi; Lisa M Noguchi; Elizabeth Montgomery; Joseph Biggio; Craig W Hendrix; Mark A Marzinke; James Y Dai; Jason Pan; Ratiya Kunjara Na Ayudhya; Jill L Schwartz; Karen Isaacs; Jeanna M Piper; D Heather Watts
Journal:  J Int AIDS Soc       Date:  2016-09-21       Impact factor: 5.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.